1. Home
  2. PRTA vs IHRT Comparison

PRTA vs IHRT Comparison

Compare PRTA & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • IHRT
  • Stock Information
  • Founded
  • PRTA 2012
  • IHRT 1974
  • Country
  • PRTA Ireland
  • IHRT United States
  • Employees
  • PRTA N/A
  • IHRT 10100
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • IHRT Broadcasting
  • Sector
  • PRTA Health Care
  • IHRT Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • IHRT Nasdaq
  • Market Cap
  • PRTA 346.4M
  • IHRT 292.3M
  • IPO Year
  • PRTA N/A
  • IHRT 2019
  • Fundamental
  • Price
  • PRTA $6.29
  • IHRT $1.93
  • Analyst Decision
  • PRTA Buy
  • IHRT Buy
  • Analyst Count
  • PRTA 9
  • IHRT 3
  • Target Price
  • PRTA $27.67
  • IHRT $2.92
  • AVG Volume (30 Days)
  • PRTA 1.3M
  • IHRT 667.1K
  • Earning Date
  • PRTA 08-07-2025
  • IHRT 08-07-2025
  • Dividend Yield
  • PRTA N/A
  • IHRT N/A
  • EPS Growth
  • PRTA N/A
  • IHRT N/A
  • EPS
  • PRTA N/A
  • IHRT N/A
  • Revenue
  • PRTA $137,935,000.00
  • IHRT $3,862,595,000.00
  • Revenue This Year
  • PRTA N/A
  • IHRT N/A
  • Revenue Next Year
  • PRTA $122.02
  • IHRT $5.89
  • P/E Ratio
  • PRTA N/A
  • IHRT N/A
  • Revenue Growth
  • PRTA 54.55
  • IHRT 3.31
  • 52 Week Low
  • PRTA $4.32
  • IHRT $0.95
  • 52 Week High
  • PRTA $25.42
  • IHRT $2.84
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 56.80
  • IHRT 62.44
  • Support Level
  • PRTA $6.16
  • IHRT $1.94
  • Resistance Level
  • PRTA $6.60
  • IHRT $2.07
  • Average True Range (ATR)
  • PRTA 0.27
  • IHRT 0.13
  • MACD
  • PRTA 0.04
  • IHRT -0.01
  • Stochastic Oscillator
  • PRTA 67.90
  • IHRT 71.28

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: